References
- Shen, Z.W., Fisinger, U., Poulev, A., Eisenreich, W., Werner, I., Pleiner, E., Bacher, A., Zenk, M.H. Tracer studies with 13C-labeled carbohydrates in cultured plant cells. Retrobiosynthetic analysis of chelidonic acid biosynthesis. Phytochemistry 2001, 57, 33–42.
- Colombo, M.L., Bosisio, E. Pharmacological activities of Chelidonium majus L. (Papaveraceae). Pharmacol Res 1996, 33, 127–134.
- Schuerwegh, A.J., Ioan-Facsinay, A., Dorjée, A.L., Roos, J., Bajema, I.M., van der Voort, E.I., Huizinga, T.W., Toes, R.E. Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis. Proc Natl Acad Sci USA 2010, 107, 2586–2591.
- Holgate, S.T. The role of mast cells and basophils in inflammation. Clin Exp Allergy 2000, 30 Suppl 1, 28–32.
- Galli, S.J., Nakae, S., Tsai, M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005, 6, 135–142.
- Marshall, J.S. Mast-cell responses to pathogens. Nat Rev Immunol 2004, 4, 787–799.
- Park, H.H., Lee, S., Son, H.Y., Park, S.B., Kim, M.S., Choi, E.J., Singh, T.S., Ha, J.H., Lee, M.G., Kim, J.E., Hyun, M.C., Kwon, T.K., Kim, Y.H., Kim, S.H. Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Arch Pharm Res 2008, 31, 1303–1311.
- Lee, S.H., Stehlik, C., Reed, J.C. Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing. J Biol Chem 2001, 276, 34495–34500.
- Wang, X., Wang, H., Figueroa, B.E., Zhang, W.H., Huo, C., Guan, Y., Zhang, Y., Bruey, J.M., Reed, J.C., Friedlander, R.M. Dysregulation of receptor interacting protein-2 and caspase recruitment domain only protein mediates aberrant caspase-1 activation in Huntington’s disease. J Neurosci 2005, 25, 11645–11654.
- Humke, E.W., Shriver, S.K., Starovasnik, M.A., Fairbrother, W.J., Dixit, V.M. ICEBERG: a novel inhibitor of interleukin-1beta generation. Cell 2000, 103, 99–111.
- Gupta, S.C., Sundaram, C., Reuter, S., Aggarwal, B.B. Inhibiting NF-?B activation by small molecules as a therapeutic strategy. Biochim Biophys Acta 2010, 1799, 775–787.
- Basak, S., Kim, H., Kearns, J.D., Tergaonkar, V., O’Dea, E., Werner, S.L., Benedict, C.A., Ware, C.F., Ghosh, G., Verma, I.M., Hoffmann, A. A fourth IkappaB protein within the NF-kappaB signaling module. Cell 2007, 128, 369–381.
- Lin, Y., Bai, L., Chen, W., Xu, S. The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin Ther Targets 2010, 14, 45–55.
- Nelson, D.E. Oscillations in NF-κB signaling control the dynamics of gene expression. Science 2004, 306, 704–708.
- Metz, M., Maurer, M. Mast cells–key effector cells in immune responses. Trends Immunol 2007, 28, 234–241.
- Woolley, D.E., Tetlow, L.C. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Arthritis Res 2000, 2, 65–74.
- Mukaida, N. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 2000, 72, 391–398.
- Nishimoto, N. Cytokine signal regulation and autoimmune disorders. Autoimmunity 2005, 38, 359–367.
- Kim, S.J., Jeong, H.J., Choi, I.Y., Lee, K.M., Park, R.K., Hong, S.H., Kim, H.M. Cyclooxygenase-2 inhibitor SC-236 [4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1-pyrazol-1-l] benzenesulfonamide] suppresses nuclear factor-kappaB activation and phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase, and c-Jun N-terminal kinase in human mast cell line cells. J Pharmacol Exp Ther 2005, 314, 27–34.
- Guo, X., Gerl, R.E., Schrader, J.W. Defining the involvement of p38alpha MAPK in the production of anti- and proinflammatory cytokines using an SB 203580-resistant form of the kinase. J Biol Chem 2003, 278, 22237–22242.
- Jeong, H.J., Chung, H.S., Lee, B.R., Kim, S.J., Yoo, S.J., Hong, S.H., Kim, H.M. Expression of proinflammatory cytokines via HIF-1alpha and NF-kappaB activation on desferrioxamine-stimulated HMC-1 cells. Biochem Biophys Res Commun 2003, 306, 805–811.
- Azzolina, A., Bongiovanni, A., Lampiasi, N. Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells. Biochim Biophys Acta 2003, 1643, 75–83.
- Boost, K.A., Hoegl, S., Hofstetter, C., Flondor, M., Stegewerth, K., Platacis, I., Pfeilschifter, J., Muhl, H., Zwissler, B. Targeting caspase-1 by inhalation-therapy: effects of Ac-YVAD-CHO on IL-1 beta, IL-18 and downstream proinflammatory parameters as detected in rat endotoxaemia. Intensive Care Med 2007, 33, 863–871.